7.5 Publication. DNDi supports the timely communication of its collaborative research, and will facilitate the rapid and accurate communication of DNDi-collaborative research and clinical trial results to the wider scientific and medical communities in the most appropriate and practicable way. Thus, each Party recognizes to the other Party the right to jointly communicate and/or publish the results generated through the activities of the Research and Development Plan. The Parties acknowledge that each Party’s researchers engaged in the Research and Development Plan shall be permitted to present at symposia, national, or regional professional meetings, and to publish in journals, theses or dissertations, or otherwise of their own choosing, selected results obtained during the performance of the Research and Development Plan, provided, however, that the publishing Party shall submit copies to the other Party of any proposed publication or presentation in advance of such proposed publication or presentation to a journal, editor, or other third party. The other Party shall have thirty (30) days, after receipt of said copies, to object or to amend such proposed presentation or publication on the grounds of the existence of a patentable subject matter for which it will seek protection. In the event that the other Party makes such determination, the publishing Party shall refrain from making such publication or presentation for a maximum of ninety (90) days from date of receipt of such determination in order to allow the other Party to file patent application(s) with the appropriate patent office(s) upon the patentable subject matter contained in the proposed publication or presentation.